T9577 |
HCV-IN-31
|
|
HCV Protease
|
|
HCV-IN-31 is a HCV inhibitor with an EC50/EC95 of 15.7 μM. |
T11541 |
HCV-IN-30
|
|
Others
,
HCV Protease
|
|
HCV-IN-30 is an HCV NS5A replication complex inhibitor (IC50s: 901 and 102 nM for genotypes 1a and 1b replicons). |
T11539 |
HCV-IN-29
|
|
HCV Protease
|
|
HCV-IN-29 is a hepatitis C virus (HCV) inhibitor. |
T32050 |
HCV-371
|
HCV 371 |
|
|
HCV-371 is a potent selective HCV NS5B polymerase inhibitor that shows broad inhibitory activity against NS5B RDRP and n... |
T27530 |
HCV-086
|
HCV086 |
|
|
HCV-086, a RNA-directed RNA polymerase (NS5B) inhibitor, is used for the treatment of HCV infection. |
TQ0090 |
Nesbuvir
|
HCV-796 |
HCV Protease
|
|
Nesbuvir is a selective hepatitis C virus (HCV) nonstructural protein 5B (NS5B) RNA-dependent polymerase inhibitor.Nesbu... |
T11548 |
HCV-IN-7
|
|
Others
|
|
HCV-IN-7 is an orally active and potent pan-genotypic HCV NS5A inhibitor (IC50s: 3-47 pM). It shows a superior pan-genot... |
T11540 |
HCV-IN-3
|
|
Others
|
|
HCV-IN-3 is a hepatitis C virus (HCV) NS3/4a protein inhibitor (IC50: 20 μM; Kd: 29 μM). |
TP1468 |
HCV-IN-4
|
|
|
|
HCV-IN-4 is a potent and orally active HCV NS5A inhibitor, shows great potency against GT1a, GT2b, GT3a, GT1a Y93H and G... |
T11548L |
HCV-IN-7 hydrochloride
|
|
Others
|
|
HCV-IN-7 hydrochloride is an orally active and potent pan-genotypic HCV NS5A inhibitor (IC50s: 3-47 pM). It shows a supe... |
T63566 |
HCV-IN-33
|
|
|
|
HCV-IN-33 (Compound (S)-3i) is an inhibitor of HCV entry. |
T74625 |
HCV-IN-41
|
|
|
|
HCV-IN-41 (compound 4) is a highly potent hepatitis C virus (HCV) inhibitor with an EC 50 value of 0.006762 nM, 5.183 nM... |
T63567 |
HCV-IN-34
|
|
|
|
HCV-IN-34 is an orally active HCV entry inhibitor. HCV-IN-35 exhibits good antiviral efficacy (EC50: 0.010 μM, CC50 (hal... |
T63406 |
HCV-IN-35
|
|
|
|
HCV-IN-35 is a potent inhibitor of HCV and shows potential for infectious disease research. |
T63396 |
HCV-IN-38
|
|
|
|
HCV-IN-38 is a selective, potent, orally active hepatitis C virus (HCV) inhibitor with an EC50 value of 15 nM and an SI ... |
T63585 |
HCV-IN-37
|
|
|
|
HCV-IN-37 is a potent inhibitor of HCV. HCV-IN-37 is able to persist in rat plasma after oral administration to rats at ... |
T63407 |
HCV-IN-36
|
|
|
|
HCV-IN-36 is an orally active HCV entry inhibitor that exhibits good antiviral activity (EC50: 0.016 μM, CC50 (half of t... |
T64202 |
HCV-IN-40
|
|
|
|
HCV-IN-39 (Compound 18a) is a potent, orally active nucleoside inhibitor of hepatitis C virus (HCV) that acts on the GT1... |
T76520 |
HCV Peptide (257-266)
|
|
|
|
HCV Peptide (257-266) is a peptide. HCV Peptide (257-266) can be used for the research of hepatitis C virus (HCV) [1] . |
T76518 |
HCV Peptide (131-140)
|
|
|
|
HCV Peptide (131-140) is a peptide. HCV Peptide (131-140) can be used for the research of hepatitis C virus (HCV) [1] . |